108 related articles for article (PubMed ID: 9815773)
61. The expression of platelet-derived endothelial cell growth factor in human bladder cancer.
Sawase K; Nomata K; Kanetake H; Saito Y
Cancer Lett; 1998 Aug; 130(1-2):35-41. PubMed ID: 9751254
[TBL] [Abstract][Full Text] [Related]
62. Arylsulfatase A activities in urine and tissues taken from bladder cancer patients.
Mitsuhashi K; Maru A; Koyanagi T; Ishibashi T; Imai Y; Gasa S; Taniguchi N; Makita A
Jpn J Exp Med; 1984 Oct; 54(5):211-6. PubMed ID: 6152561
[TBL] [Abstract][Full Text] [Related]
63. Augmentation of antitumor activity of 5'-deoxy-5-fluorouridine by thymosin fraction 5 in mouse bladder cancer cells in vitro and in vivo.
Ikemoto S; Sugimura K; Wada S; Yasumoto R; Yamamoto K; Kishimoto T
Cancer Lett; 1999 Oct; 145(1-2):121-6. PubMed ID: 10530779
[TBL] [Abstract][Full Text] [Related]
64. [Enzymatic conversion of tegafur in human tumor tissue].
Hara Y; Sugata S; Kono A; Tanaka M
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1511-7. PubMed ID: 6409007
[TBL] [Abstract][Full Text] [Related]
65. [Enzymological study of bladder tumor. II. Lactic dehydrogenase, alkaline phosphatase activity and LDH isoenzymes in the tissue of bladder cancer: the relations with stage and histological grade].
Ishibe T; Nihira H
Hinyokika Kiyo; 1970 Feb; 16(2):68-72. PubMed ID: 5462080
[No Abstract] [Full Text] [Related]
66. [The analysis of thymidine phosphorylase examined by ELISA in bladder cancer].
Saegusa M; Takao A; Manabe D; Ichikawa T; Aramaki K; Nakayama Y; Yamada D
Nihon Hinyokika Gakkai Zasshi; 2002 Nov; 93(7):743-9. PubMed ID: 12494519
[TBL] [Abstract][Full Text] [Related]
67. [5'-Deoxy-5-fluorouridine and 5-fluorouracil concentrations and thymidine phosphorylase activity in brain tumors following intravenous administration of 5'-deoxy-5-fluorouridine].
Yamashita M; Hashimoto T; Hirakawa T; Fukushima T; Tomonaga M; Hara Y; Kono A; Tanaka M
Neurol Med Chir (Tokyo); 1985 Aug; 25(8):613-9. PubMed ID: 2415854
[No Abstract] [Full Text] [Related]
68. [In vivo study on intrathecal use of 5-fluoro-2'-deoxyuridine (FdUrd) in meningeal dissemination of malignant tumor].
Nakagawa H; Yamada M; Fukushima M; Shimizu K; Ikenaka K
No Shinkei Geka; 1998 Oct; 26(10):873-9. PubMed ID: 9789291
[TBL] [Abstract][Full Text] [Related]
69. Elastase--does this enzyme play any role in bladder cancer invasion?
Nemoto S; Koiso K; Aoyagi K; Tojo S
J Urol; 1985 Nov; 134(5):996-8. PubMed ID: 3903222
[TBL] [Abstract][Full Text] [Related]
70. Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.
Kono A; Hara Y; Sugata S; Karube Y; Matsushima Y; Ishitsuka H
Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):175-8. PubMed ID: 6221809
[No Abstract] [Full Text] [Related]
71. Enzymatic cleavage of various fluorinated pyrimidine nucleosides to 5-fluorouracil and their antiproliferative activities in human and murine tumor cells.
Miwa M; Cook A; Ishitsuka H
Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4225-32. PubMed ID: 2951016
[No Abstract] [Full Text] [Related]
72. Polyunsaturated fatty acid metabolizing 15-Lipoxygenase-1 (15-LO-1) expression in normal and tumorigenic human bladder tissues.
Philips BJ; Dhir R; Hutzley J; Sen M; Kelavkar UP
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):159-64. PubMed ID: 18227726
[TBL] [Abstract][Full Text] [Related]
73. Viewpoints on the current treatments of bladder tumors.
Wajsman Z; Beckley S; Murphy GP
Curr Surg; 1980; 37(1):1-7. PubMed ID: 7371428
[No Abstract] [Full Text] [Related]
74. Biochemical basis for circadian-dependent metabolism of fluoropyrimidines.
Daher GC; Harris BE; Willard EM; Diasio RB
Ann N Y Acad Sci; 1991; 618():350-61. PubMed ID: 1826077
[No Abstract] [Full Text] [Related]
75. Thiothymidine combined with UVA as a potential novel therapy for bladder cancer.
Pridgeon SW; Heer R; Taylor GA; Newell DR; O'Toole K; Robinson M; Xu YZ; Karran P; Boddy AV
Br J Cancer; 2011 Jun; 104(12):1869-76. PubMed ID: 21610703
[TBL] [Abstract][Full Text] [Related]
76. [A study of invasive factor in bladder cancer--elastase-like activity as a marker of bladder cancer invasiveness].
Nemoto S; Koiso K; Aoyagi K; Tojo S
Nihon Hinyokika Gakkai Zasshi; 1984 Sep; 75(9):1391-400. PubMed ID: 6569901
[No Abstract] [Full Text] [Related]
77. Why do most primary bladder neoplasms first appear around the ureteric orifices?
Stewart LH; O'Neill KL; McKelvey VJ; Gillespie ES; Johnston SR; Biggart JD; McKenna PG
Br J Urol; 1993 Jan; 71(1):34-7. PubMed ID: 8435734
[TBL] [Abstract][Full Text] [Related]
78. [Identification of RalGAPs and their downregulation in invasive bladder cancer].
Shirakawa R; Horiuchi H
Seikagaku; 2014 Oct; 86(5):671-5. PubMed ID: 25509336
[No Abstract] [Full Text] [Related]
79. Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors.
Bijnsdorp IV; Capriotti F; Kruyt FA; Losekoot N; Fukushima M; Griffioen AW; Thijssen VL; Peters GJ
Br J Cancer; 2011 Mar; 104(7):1185-92. PubMed ID: 21386840
[TBL] [Abstract][Full Text] [Related]
80. Thymidylate synthase inhibition induces p53-dependent and p53-independent apoptotic responses in human urinary bladder cancer cells.
Stravopodis DJ; Karkoulis PK; Konstantakou EG; Melachroinou S; Thanasopoulou A; Aravantinos G; Margaritis LH; Anastasiadou E; Voutsinas GE
J Cancer Res Clin Oncol; 2011 Feb; 137(2):359-74. PubMed ID: 20425122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
